These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27172693)

  • 1. [Off-label indications of biological drugs in dermatology].
    Cortés B; Laffitte E
    Rev Med Suisse; 2016 Mar; 12(512):635-8. PubMed ID: 27172693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics for pityriasis rubra pilaris treatment: A review of the literature.
    Napolitano M; Abeni D; Didona B
    J Am Acad Dermatol; 2018 Aug; 79(2):353-359.e11. PubMed ID: 29609014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics in dermatology beyond psoriasis.
    Han G
    Cutis; 2014 May; 93(5):E21-7. PubMed ID: 24897148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine for use in dermatology.
    Gendler E
    J Dermatol Surg Oncol; 1984 Jun; 10(6):462-4. PubMed ID: 6725741
    [No Abstract]   [Full Text] [Related]  

  • 5. Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients.
    Sand FL; Thomsen SF
    Dermatol Ther; 2015; 28(3):158-65. PubMed ID: 25731720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label uses of ustekinumab.
    Ye L; Wu Z; Li C; Zhao X; Wan M; Wang L
    Dermatol Ther; 2022 Dec; 35(12):e15910. PubMed ID: 36208443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study.
    Klein A; Coras B; Landthaler M; Babilas P
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1400-6. PubMed ID: 22007931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate and its uses in dermatology.
    Jetton RL
    Med Times; 1970 Jun; 98(6):83-92. PubMed ID: 4910984
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-interleukin-17A for pityriasis rubra pilaris: catching the psoriasis biologic wave.
    Balak DMW; Rissmann R
    Br J Dermatol; 2022 Nov; 187(5):633-634. PubMed ID: 35996840
    [No Abstract]   [Full Text] [Related]  

  • 10. [What's new in pediatric dermatology?].
    Mazereeuw-Hautier J
    Ann Dermatol Venereol; 2009 Dec; 136 Suppl 7():S426-35. PubMed ID: 20110058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive treatment of skin diseases. II. Clinical use of immunosuppressive drugs].
    Ruszczak Z
    Przegl Dermatol; 1974; 61(4):529-35. PubMed ID: 4603603
    [No Abstract]   [Full Text] [Related]  

  • 12. Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris?
    Balestri R; Bardazzi F; Antonucci A
    Br J Dermatol; 2010 Oct; 163(4):896-7; author reply 897-8. PubMed ID: 20662839
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pityriasis rubra pilaris: 3 cases with biologics].
    Sarles C; Valois A; Abed S; Boyé T; Fouet B; Morand JJ
    Ann Dermatol Venereol; 2019 Apr; 146(4):304-306. PubMed ID: 30929873
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient experiences with biologics and apremilast in pityriasis rubra pilaris: A patient survey.
    Maloney NJ; Kim MM; Nguyen KA; Hisaw LD; Worswick S
    Dermatol Ther; 2019 Sep; 32(5):e13060. PubMed ID: 31397958
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy.
    Ruiz Villaverde R; Sánchez Cano D
    Eur J Dermatol; 2010; 20(5):630-1. PubMed ID: 20605773
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the treatment of diseases of the skin.
    Pegum JS
    Practitioner; 1972 Oct; 209(252):453-9. PubMed ID: 4264252
    [No Abstract]   [Full Text] [Related]  

  • 17. Pityriasis rubra pilaris: evolution of challenges in promising treatment options.
    Sehgal VN; Srivastava G; Verma P
    Skinmed; 2012; 10(1):18-23. PubMed ID: 22324172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review.
    Sood S; Akuffo-Addo E; Yeung J; Mufti A
    J Am Acad Dermatol; 2023 Dec; 89(6):1306-1308. PubMed ID: 37640244
    [No Abstract]   [Full Text] [Related]  

  • 19. [What's new in dermatological therapy?].
    Meunier L
    Ann Dermatol Venereol; 2014 Dec; 141 Suppl 4():S643-53. PubMed ID: 25539756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label use in dermatology in Germany: what has changed since 2004.
    Brockmeyer NH; Brucklacher U; Potthoff A; Reich-Schupke S
    J Dtsch Dermatol Ges; 2009 Nov; 7(11):938-45. PubMed ID: 19386019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.